Genome response to tissue plasminogen activator in experimental ischemic stroke

被引：13
作者：
Jickling, Glen C. [1 ,2 ]
Zhan, Xinhua [1 ,2 ]
Ander, Bradley P. [1 ,2 ]
Turner, Renee [1 ,2 ]
Stamova, Boryana [1 ,2 ]
Xu, Huichun [1 ,2 ]
Tian, Yingfang [1 ,2 ]
Liu, Dazhi [1 ,2 ]
Davis, Ryan R. [1 ,2 ]
Lapchak, Paul A. [3 ]
Sharp, Frank R. [1 ,2 ]
机构：
[1] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA
[2] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA
[3] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA
来源：
BMC GENOMICS | 2010年 / 11卷
关键词：
BLOOD-BRAIN-BARRIER; GENE-EXPRESSION; INTRACEREBRAL HEMORRHAGE; MATRIX-METALLOPROTEINASE; THROMBOLYTIC THERAPY; CELLS; MATRIX-METALLOPROTEINASE-9; NEUTROPHILS; DISRUPTION; MONOCYTES;
D O I：
10.1186/1471-2164-11-254
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Background: Tissue plasminogen activator (tPA) is known to have functions beyond fibrinolysis in acute ischemic stroke, such as blood brain barrier disruption. To further delineate tPA functions in the blood, we examined the gene expression profiles induced by tPA in a rat model of ischemic stroke. Results: tPA differentially expressed 929 genes in the blood of rats (p <= 0.05, fold change >= vertical bar 1.2 vertical bar). Genes identified had functions related to modulation of immune cells. tPA gene expression was found to be dependent on the reperfusion status of cerebral vasculature. The majority of genes regulated by tPA were different from genes regulated by ischemic stroke. Conclusions: tPA modulates gene expression in the blood of rats involving immune cells in a manner that is dependent on the status of vascular reperfusion. These non-fibrinolytic activities of tPA in the blood serve to better understand tPA-related complications.
引用
收藏
页数：10
相关论文
共 50 条
  • [41] Update on the effects of treatment with recombinant tissue-type plasminogen activator (rt-PA) in acute ischemic stroke
    Bonaventura, Aldo
    Montecucco, Fabrizio
    Dallegri, Franco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (11) : 1323 - 1340
  • [42] Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Induced Brain Hemorrhagic Transformation After Ischemic Stroke
    Xie, Guanfeng
    Jiang, Gege
    Huang, Liqin
    Sun, Shangqi
    Li, Xiaoyi
    Wu, Bingjie
    Wang, Hualong
    Zhang, Zhentao
    Ye, Keqiang
    Yu, Ying
    Xiong, Jing
    CNS NEUROSCIENCE & THERAPEUTICS, 2025, 31 (03)
  • [43] TISSUE PLASMINOGEN ACTIVATOR AND STROKE: REVIEW OF THE LITERATURE FOR THE CLINICIAN
    DeMers, Gerard
    Meurer, William J.
    Shih, Richard
    Rosenbaum, Steve
    Vilke, Gary M.
    JOURNAL OF EMERGENCY MEDICINE, 2012, 43 (06) : 1149 - 1154
  • [44] High-density Lipoprotein-based Therapy Reduces the Hemorrhagic Complications Associated With Tissue Plasminogen Activator Treatment in Experimental Stroke
    Lapergue, Bertrand
    Bao Quoc Dang
    Desilles, Jean-Philippe
    Ortiz-Munoz, Guadalupe
    Delbosc, Sandrine
    Loyau, Stephane
    Louedec, Liliane
    Couraud, Pierre-Olivier
    Mazighi, Mikael
    Michel, Jean-Baptiste
    Meilhac, Olivier
    Amarenco, Pierre
    STROKE, 2013, 44 (03) : 699 - 707
  • [45] Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers
    Wang, Wei
    Li, Mingchang
    Chen, Qianxue
    Wang, Jian
    MOLECULAR NEUROBIOLOGY, 2015, 52 (03) : 1572 - 1579
  • [46] Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke
    Hu, Jiangnan
    Huang, Shengwei
    Zhu, Lu
    Huang, Weijie
    Zhao, Yiping
    Jin, Kunlin
    ZhuGe, Qichuan
    ACS APPLIED MATERIALS & INTERFACES, 2018, 10 (39) : 32988 - 32997
  • [47] Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers
    Wei Wang
    Mingchang Li
    Qianxue Chen
    Jian Wang
    Molecular Neurobiology, 2015, 52 : 1572 - 1579
  • [48] Repurposing an Old Drug to Improve the Use and Safety of Tissue Plasminogen Activator for Acute Ischemic Stroke: Minocycline
    Hess, David C.
    Fagan, Susan C.
    PHARMACOTHERAPY, 2010, 30 (07): : 55S - 61S
  • [49] Enhanced thrombolysis using tissue plasminogen activator (tPA)-loaded PEGylated PLGA nanoparticles for ischemic stroke
    Zamanlu, Masumeh
    Eskandani, Morteza
    Barar, Jaleh
    Jaymand, Mehdi
    Pakchin, Parvin Samadi
    Farhoudi, Mehdi
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 53
  • [50] Cost-Effectiveness of Recombinant Tissue Plasminogen Activator in the Management of Acute Ischemic Stroke: A Systematic Review
    Jung, Kee-Taig
    Shin, Dong Wook
    Lee, Kyung-Jin
    Oh, Myungju
    JOURNAL OF CLINICAL NEUROLOGY, 2010, 6 (03): : 117 - 126
12345